CuraTeQ Biologics Pvt., an Aurobindo Pharma subsidiary, was given a Good Manufacturing Practice certificate of compliance for its biosimilars manufacturing facility from the European Medicines ...
Aurobindo Pharma subsidiary CuraTeQ Biologics has received a GMP certificate of compliance for its biosimilars manufacturing facility from the European Medicines Agency (EMA). The GMP inspection ...
Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in consolidated revenue, driven by a strong ...